MedPath

FERNGROVE PHARMACEUTICALS AUSTRALIA PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

58

TGA:58

Drug Approvals

Hepatothin (492071)

Product Name
Hepatothin
Approval Date
Jun 18, 2025
TGA

Strongstart (490767)

Product Name
Strongstart
Approval Date
Jun 4, 2025
TGA

Longevity Age Code (490130)

Product Name
Longevity Age Code
Approval Date
May 27, 2025
TGA

BioResisté (489127)

Product Name
BioResisté
Approval Date
May 19, 2025
TGA

Immune Boost (489133)

Product Name
Immune Boost
Approval Date
May 19, 2025
TGA

DHA (485008)

Product Name
DHA
Approval Date
Apr 2, 2025
TGA

Grapeseed (480771)

Product Name
Grapeseed
Approval Date
Feb 25, 2025
TGA

Omega3 1000mg double strength (476505)

Product Name
Omega3 1000mg double strength
Approval Date
Jan 23, 2025
TGA

PQQ + Snow Lotus (472525)

Product Name
PQQ + Snow Lotus
Approval Date
Dec 10, 2024
TGA

Selenium Ultra (469672)

Product Name
Selenium Ultra
Approval Date
Nov 21, 2024
TGA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.